AURORA CANNABIS ( ACB NYSE )

SHORT SUPPLY - AT MAX PRODUCTIONS LEVELS NOT ENOUGH

Featured Company - Pharmagreen Biotech Inc - PHBI OTC - Small Cap Cannabis Pick


Summary - Whats Happening In Canada

Government projections for cannabis in Canada are likely to fall short of expectations just as they did with demand expectations in the country on legalization day.

Future supply will be limited, considering demand growth in cannabis, and this issue will persist for a couple of years to come.  Plantlets For Sale To Growers

Aurora Cannabis has the ability to roll out their low-cost, fully-automated production facilities that utilize fewer employees; Aurora will be able to respond and capitalize easily. Day Trader

Booming cannabis sales for Canada 2019 expected at C$5 Billion

Midas Letter Video  / Aurora Cannabis Inc  

Three to four month seed to weed lag period

35%-40% user growth

Government projections for cannabis sales in Canada are expected to be some C$5B in legal cannabis for 2019. The problem is that the vast majority of major players are going to be coming online with their biggest facilities over the summer and through to the end of the year. There is a 3-4-month "seed-to-weed" factor that needs to be taken into account. I question if there will be enough supply to keep up with the demand for products through the rest of the year.  Tesla - Consumer Reports Downgrade  - Here Is Why

Then, there is a secondary issue: The growth of usage over the course of the next 1-2 years. Given a comparison of Canada and Colorado, sales could increase some 45% by the end of 2020 and then another 35% the year after that. From the top major producers, there will not be enough supply to hit the market over the course of the next few years to keep up with demand.  Four Biotechs To Buy Today

This Marijuana ETF since Dec 2018, has moved ahead over 50% showing the high volitility in the industry and why we should be circuling back to the small cap arena that is playing catch up . Stocks such as  Pharmagreen Biotech - OTC PHBI

MARIJUANA ETF

Given this backdrop, we believe that Aurora Cannabis (ACB) may be able to capitalize handsomely under that backdrop. Cannabis is being commoditized down to the lowest cost-basis possible. And, with their ultra-automation approach, Aurora Cannabis may have the best blueprint for rolling out additional supply and succeed in an ultra-competitive environment.

AURORA

What Can Canada Expect

How much cannabis will Canada need is a question that elicits a multitude of responses. We are driven by data and usually point to that as the basis of our thinking.

Crypto Crime - The Perfect Heist  

 

 

 

About WallStreetResearcher.com : 
 WallStreetResearcher.com is a subsidiary of Target Publishing Inc, and is a leading publisher of todays market and investment news, commentary, proprietary research and videos from seasoned journalists, analysts and contributors covering the financial markets and global economies. Leveraging our extensive distribution network and social media presence, we have cultivated a valuable audience of engaged market enthusiasts, which in turn delivers a variety of unique opportunXities for industry partnerships, corporate communications, market exposure and investment. The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility
A complete disclaimer can be viewed HERE